It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug ...

Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...

the company's decision to construct new manufacturing sites in the U.S., creating thousands of jobs, indicates an aggressive expansion strategy. Such advances likely contributed to Eli Lilly's ...

Eli Lilly has recently unveiled significant advancements across its product line, including promising results from the BRAVE-AA-PEDS study on adolescents ... to build four new manufacturing ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares leaving ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Advertisement Eli Lilly chairman and Chief Executive Officer ... threatening heart condition than people who don't indulge, a new study says. Health News // 6 hours ago Seniors benefit from ...

We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at ...

New results show Eli Lilly (LLY) and Company’s Ebglyss achieved ... These findings from the ADjoin long-term extension study will be presented at the American Academy of Dermatology Annual ...